IVVD insider transaction filings
Invivyd, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-02. Screen IVVD transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 8 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 5 filings by 5 insiders — 228,024 shares, $177,089 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 37,256 shares @ $0.72 ($26,899) by Andersen Jill, filed 2026-08-18.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Andersen Jill — Chief Legal Officer, Secretary | 1 | — | 2 legs · 67,962 sh · $52,781 | 2 |
| Duke William E. — Chief Financial Officer | 1 | — | 2 legs · 40,780 sh · $31,671 | 2 |
| Green Julie — Chief Human Resources Officer | 1 | — | 2 legs · 40,780 sh · $31,671 | 2 |
| Lee Timothy Edward — Chief Commercial Officer | 1 | — | 2 legs · 40,780 sh · $31,671 | 2 |
| Allen Robert D. III — Chief Scientific Officer | 1 | — | 2 legs · 37,722 sh · $29,296 | 2 |
| Elia Marc — Chief Executive Officer, Director | 1 | — | — | 1 |
| Mina Michael — CMO and Chief Epidemiologist | 1 | — | — | 1 |
| Sheffield Ian — Director | 1 | — | — | 1 |
Recent Form 4 filings — Invivyd, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | Sheffield Ian — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-09-01 | 4 | Elia Marc — Chief Executive Officer, Director | Grant/award (A): 10,700,000 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | Duke William E. — Chief Financial Officer | Option exercise (M): 102,000 · Sale (S): 22,355 @ $0.72 · Sale (S): 18,425 @ $0.84 · Option exercise (M): 102,000 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | Green Julie — Chief Human Resources Officer | Option exercise (M): 102,000 · Sale (S): 22,355 @ $0.72 · Sale (S): 18,425 @ $0.84 · Option exercise (M): 102,000 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | Lee Timothy Edward — Chief Commercial Officer | Option exercise (M): 102,000 · Sale (S): 22,355 @ $0.72 · Sale (S): 18,425 @ $0.84 · Option exercise (M): 102,000 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | Allen Robert D. III — Chief Scientific Officer | Option exercise (M): 102,000 · Sale (S): 20,679 @ $0.72 · Sale (S): 17,043 @ $0.84 · Option exercise (M): 102,000 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | Andersen Jill — Chief Legal Officer, Secretary | Option exercise (M): 170,000 · Sale (S): 37,256 @ $0.72 · Sale (S): 30,706 @ $0.84 · Option exercise (M): 170,000 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | Mina Michael — CMO and Chief Epidemiologist | Grant/award (A): 1,125,000 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | Royan Ajay — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | Berry Tamsin — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | Elia Marc — Director M28 Capital Management LP | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | BOLNO PAUL — Director | Grant/award (A): 32,876 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | MCLAUGHLIN KEVIN F — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | MCGUIRE TERRANCE — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Allen Robert D. III — Chief Scientific Officer | Option exercise (M): 99,000 · Sale (S): 18,189 @ $1.54 · Sale (S): 19,392 @ $1.58 · Option exercise (M): 99,000 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Green Julie — Chief Human Resources Officer | Option exercise (M): 99,000 · Sale (S): 19,663 @ $1.54 · Sale (S): 20,964 @ $1.58 · Option exercise (M): 99,000 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Lee Timothy Edward — Chief Commercial Officer | Option exercise (M): 99,000 · Sale (S): 19,663 @ $1.54 · Sale (S): 20,964 @ $1.58 · Option exercise (M): 99,000 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Andersen Jill — Chief Legal Officer, Secretary | Option exercise (M): 165,000 · Sale (S): 32,771 @ $1.54 · Sale (S): 34,939 @ $1.58 · Option exercise (M): 165,000 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Duke William E. — Chief Financial Officer | Option exercise (M): 99,000 · Sale (S): 19,663 @ $1.54 · Sale (S): 20,964 @ $1.58 · Option exercise (M): 99,000 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Green Julie — Chief Human Resources Officer | Grant/award (A): 675,000 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Lee Timothy Edward — Chief Commercial Officer | Grant/award (A): 675,000 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Andersen Jill — Chief Legal Officer, Secretary | Grant/award (A): 820,000 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Allen Robert D. III — Chief Scientific Officer | Grant/award (A): 625,000 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Duke William E. — Chief Financial Officer | Grant/award (A): 625,000 (derivative) @ $0 | EDGAR |
| 2025-11-20 | 4 | MCLAUGHLIN KEVIN F — Director | Purchase (P): 50,000 @ $2.50 | EDGAR |
| 2025-09-24 | 4 | BOLNO PAUL — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | Lee Timothy Edward — Chief Commercial Officer | Option exercise (M): 99,000 · Sale (S): 20,013 @ $0.65 · Sale (S): 29,643 @ $0.57 · Option exercise (M): 99,000 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | Green Julie — Chief Human Resources Officer | Option exercise (M): 99,000 · Sale (S): 20,013 @ $0.65 · Sale (S): 29,643 @ $0.57 · Option exercise (M): 99,000 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | Andersen Jill — Chief Legal Officer, Secretary | Option exercise (M): 165,000 · Sale (S): 33,352 @ $0.65 · Sale (S): 49,402 @ $0.57 · Option exercise (M): 165,000 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | Allen Robert D. III — Chief Scientific Officer | Option exercise (M): 99,000 · Sale (S): 18,512 @ $0.65 · Sale (S): 27,420 @ $0.57 · Option exercise (M): 99,000 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | Duke William E. — Chief Financial Officer | Option exercise (M): 99,000 · Sale (S): 20,013 @ $0.65 · Sale (S): 29,643 @ $0.57 · Option exercise (M): 99,000 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Berry Tamsin — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Lindenboom Christine — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Royan Ajay — Director | Grant/award (A): 8,219 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Elia Marc — Director M28 Capital Management LP | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | MCLAUGHLIN KEVIN F — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | MCGUIRE TERRANCE — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | Royan Ajay — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Andersen Jill — Chief Legal Officer, Secretary | Grant/award (A): 950,000 (derivative) @ $0 · Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Allen Robert D. III — Chief Scientific Officer | Grant/award (A): 950,000 (derivative) @ $0 · Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Green Julie — Chief Human Resources Officer | Grant/award (A): 950,000 (derivative) @ $0 · Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Lee Timothy Edward — Chief Commercial Officer | Grant/award (A): 950,000 (derivative) @ $0 · Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Duke William E. — Chief Financial Officer | Grant/award (A): 950,000 (derivative) @ $0 · Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2024-12-31 | 4 | MCGUIRE TERRANCE — Director | Sale (S): 83,744 @ $0.52 · Sale (S): 86,545 @ $0.48 · Sale (S): 103,474 @ $0.45 | EDGAR |
| 2024-12-26 | 4 | MCGUIRE TERRANCE — Director | Sale (S): 119,805 @ $0.42 · Sale (S): 75,776 @ $0.45 · Sale (S): 68,161 @ $0.51 · Sale (S): 83,817 @ $0.54 | EDGAR |
| 2024-12-19 | 4 | MCGUIRE TERRANCE — Director | Sale (S): 97,410 @ $0.48 · Sale (S): 74,764 @ $0.47 · Sale (S): 152,067 @ $0.43 | EDGAR |
| 2024-12-16 | 4 | MCGUIRE TERRANCE — Director | Sale (S): 125,000 @ $0.58 · Sale (S): 65,359 @ $0.47 | EDGAR |
| 2024-12-11 | 4 | MCGUIRE TERRANCE — Director | Sale (S): 150,000 @ $0.61 · Sale (S): 175,000 @ $0.59 · Sale (S): 160,400 @ $0.59 | EDGAR |
| 2024-06-06 | 4 | Lee Timothy Edward — Chief Commercial Officer | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | MCGUIRE TERRANCE — Director | Sale (S): 112,381 @ $1.66 | EDGAR |
Recent 8-K events — Invivyd, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-24 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-07-06 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-19 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-09 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-05 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-08 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-23 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=IVVD returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →